MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells

Oncology Reports

Volumn 34, Issue 1, 2015, Pages 111-120

  Zhou, Jun ^a,b,c   Xie, Ming ^c   Shi, Ying ^a,b   Luo, Baihua ^a,b   Gong, Guanghui ^a,b   Li, Juanni ^a,b   Wang, Junpu ^a,b   Zhao, Wenjian ^c   Zi, Yuan ^c   Wu, Xiaoying ^a,b   Wen, Jifang ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c XIANGNAN UNIVERSITY   (China)

Author keywords

MicroRNA 153; SET7; Tumor suppressor; ZEB2

Indexed keywords

CELL PROTEIN; MICRORNA; MICRORNA 153; SET7 PROTEIN; UNCLASSIFIED DRUG; ZEB2 PROTEIN; 3' UNTRANSLATED REGION; HISTONE LYSINE METHYLTRANSFERASE; HOMEODOMAIN PROTEIN; MIRN153 MICRORNA, HUMAN; REPRESSOR PROTEIN; SETD7 PROTEIN, HUMAN; ZEB2 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA BINDING; RNA DEGRADATION; SET7 GENE; SURVIVAL RATE; SURVIVAL TIME; TUMOR INVASION; TUMOR SUPPRESSOR GENE; UPREGULATION; ZEB2 GENE; BIOSYNTHESIS; FEMALE; GENETICS; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE-LYSINE N-METHYLTRANSFERASE; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; REPRESSOR PROTEINS;

EID: 84930023527     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3952     Document Type: Article

References (36)

1. Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233, 2009.
2. Shukla GC, Singh J and Barik S: MicroRNAs: Processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol 3: 83-92, 2011.
3. Behm-Ansmant I, Rehwinkel J and Izaurralde E: MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb Symp Quant Biol 71: 523-530, 2006.
4. Chen Y, Zhang L and Hao Q: Candidate microRNA biomarkers in human epithelial ovarian cancer: Systematic review profiling studies and experimental validation. Cancer Cell Int 13: 86, 2013.
5. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
6. Wang JL, Hu Y, Kong X, Wang ZH, Chen HY, Xu J and Fang JY: Candidate microRNA biomarkers in human gastric cancer: A systematic review and validation study. PLoS One 8: e73683, 2013.
7. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR and Israel MA: Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468, 2007.
8. Iorio MV and Croce CM: MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4: 143-159, 2012.
9. Esquela-Kerscher A and Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
10. Reynolds EA and Moller KA: A review and an update on the screening of epithelial ovarian cancer. Curr Probl Cancer 30: 203-232, 2006.
11. Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ, Xu X and Hamilton TC: Focus on epithelial ovarian cancer. Cancer Cell 5: 19-24, 2004.
12. Shan W and Liu J: Epithelial ovarian cancer: Focus on genetics and animal models. Cell Cycle 8: 731-735, 2009.
13. Farley J, Ozbun LL and Birrer MJ: Genomic analysis of epithelial ovarian cancer. Cell Res 18: 538-548, 2008.
14. Miyamoto M, Takano M, Goto T, Kato M, Sasaki N, Tsuda H and Furuya K: Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: A single institutional case series through central pathologic review. J Gynecol Oncol 24: 37-43, 2013.
15. Shih IeM and Kurman RJ: Ovarian tumorigenesis: A proposed model based on morphological and molecular genetic analysis. Am J Pathol 164: 1511-1518, 2004.
16. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D and van Roy F: The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267-1278, 2001.
17. Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van Roy F and Berx G: SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 33: 6566-6578, 2005.
18. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S, et al: Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14: 79-89, 2008.
19. You J, Li Y, Fang N, Liu B, Zu L, Chang R, Li X and Zhou Q: MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2. PLoS One 9: e91827, 2014.
20. Peinado H, Olmeda D and Cano A: Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428, 2007.
21. Gemmill RM, Roche J, Potiron VA, Nasarre P, Mitas M, Coldren CD, Helfrich BA, Garrett-Mayer E, Bunn PA and Drabkin HA: ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett 300: 66-78, 2011.
22. Bindels S, Mestdagt M, Vandewalle C, Jacobs N, Volders L, Noël A, van Roy F, Berx G, Foidart JM and Gilles C: Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 25: 4975-4985, 2006.
23. Deering TG, Ogihara T, Trace AP, Maier B and Mirmira RG: Methyltransferase Set7/9 maintains transcription and euchromatin structure at islet-enriched genes. Diabetes 58: 185-193, 2009.
24. Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C and Kouzarides T: Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 6: 73-77, 2004.
25. Pradhan S, Chin HG, Estève PO and Jacobsen SE: SET7/9 mediated methylation of non-histone proteins in mammalian cells. Epigenetics 4: 383-387, 2009.
26. Tao Y, Neppl RL, Huang ZP, Chen J, Tang RH, Cao R, Zhang Y, Jin SW and Wang DZ: The histone methyltransferase Set7/9 promotes myoblast differentiation and myofibril assembly. J Cell Biol 194: 551-565, 2011.
27. Keating ST, Ziemann M, Okabe J, Khan AW, Balcerczyk A and El-Osta A: Deep sequencing reveals novel Set7 networks. Cell Mol Life Sci 71: 4471-4486, 2014.
28. Kouzarides T: Chromatin modifications and their function. Cell 128: 693-705, 2007.
29. Bracken CP, Li X, Wright JA, Lawrence DM, Pillman KA, Salmanidis M, Anderson MA, Dredge BK, Gregory PA, Tsykin A, et al: Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion. EMBO J 33: 2040-2056, 2014.
30. Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, et al: Tumour angiogenesis regulation by the miR-200 family. Nat Commun 4: 2427, 2013.
31. Cheng W, Liu T, Wan X, Gao Y and Wang H: MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. FEBS J 279: 2047-2059, 2012.
32. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
33. Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, Zhan R and He X: Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region. Oncogene 29: 2302-2308, 2010.
34. Tili E, Michaille JJ and Croce CM: MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol Rev 253: 167-184, 2013.
35. Yanokura M, Banno K, Kobayashi Y, Kisu I, Ueki A, Ono A, Masuda K, Nomura H, Hirasawa A, Susumu N, et al: MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review). Oncol Lett 1: 935-940, 2010.
36. Zhao S, Deng Y, Liu Y, Chen X, Yang G, Mu Y, Zhang D, Kang J and Wu Z: MicroRNA-153 is tumor suppressive in glioblastoma stem cells. Mol Biol Rep 40: 2789-2798, 2013.